Internal Security Act (Singapore)

Notice - DEREK SCHEINMAN, File No. 2023-23

Retrieved on: 
Tuesday, November 14, 2023
Reason (argument), Internal Security Act (Singapore), Tribunal, Holding company, Publishing

TORONTO, Nov. 14, 2023 /CNW/ - The Tribunal issued its Reasons and Decision and an Order pursuant to Subsections 127(1) and 127(10) of the Securities Act in the above-named matter.

Key Points: 
  • TORONTO, Nov. 14, 2023 /CNW/ - The Tribunal issued its Reasons and Decision and an Order pursuant to Subsections 127(1) and 127(10) of the Securities Act in the above-named matter.
  • A copy of the Reasons and Decision and the Order both dated November 13, 2023 are available at capitalmarketstribunal.ca

Notice - KENTON ROY RUSTULKA, File No. 2023-9

Retrieved on: 
Monday, October 30, 2023
Tribunal, Order, Reason (argument), Internal Security Act (Singapore), Holding company, Mail

TORONTO, Oct. 30, 2023 /CNW/ - The Tribunal issued its Reasons and Decision and an Order pursuant to Subsections 127(1) and 127(10) of the Securities Act in the above-named matter.

Key Points: 

TORONTO, Oct. 30, 2023 /CNW/ - The Tribunal issued its Reasons and Decision and an Order pursuant to Subsections 127(1) and 127(10) of the Securities Act in the above-named matter.
A copy of the Reasons and Decision and the Order dated October 27, 2023 are available at capitalmarketstribunal.ca

Notice - ZAHIR "ZIP" SADRUDIN DHANANI and ROBERT JAMES NASO, File No. 2023-14

Retrieved on: 
Friday, September 29, 2023
Reason (argument), Tribunal, Internal Security Act (Singapore), Holding company

TORONTO, Sept. 29, 2023 /CNW/ - The Tribunal issued its Reasons and Decision and an Order pursuant to Subsections 127(1) and 127(10) of the Securities Act in the above named matter.

Key Points: 
  • TORONTO, Sept. 29, 2023 /CNW/ - The Tribunal issued its Reasons and Decision and an Order pursuant to Subsections 127(1) and 127(10) of the Securities Act in the above named matter.
  • A copy of the Reasons and Decision and the Order both dated September 28, 2023 are available at capitalmarketstribunal.ca

Submit Your Information: Johnson Fistel Urges Shareholders to Join Terran Class Action Lawsuit

Retrieved on: 
Friday, February 24, 2023
Learning, NYSE, Internal Security Act (Singapore), LLP, Court, Effective date, SAN, Employment, LLAP, Defendant, Mergers and acquisitions, Tobacco, Prospectus, Terran

SAN DIEGO, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Terran Orbital Inc., ("Terran") (NYSE: LLAP).

Key Points: 
  • SAN DIEGO, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Terran Orbital Inc., ("Terran") (NYSE: LLAP).
  • The class action is on behalf of shareholders who purchased Terran securities who purchased their stock before March 28, 2022 (the "Class Period".
  • The Terran class action lawsuit charges Terran and certain of its officers with violations of securities laws.
  • An investor's ability to share any potential future recovery of the Terran class action lawsuit is not dependent upon serving as lead plaintiff.

Class Action Deadline Reminder: Atlassian and Block, Inc: Johnson Fistel Encourages Shareholders to Submit Their Information

Retrieved on: 
Thursday, February 23, 2023
Learning, Block, Internal Security Act (Singapore), LLP, Australian Securities Exchange, CDI, Class Action, Acquisition, Action Replay, Complaint, SQ, SAN, Sale, Scheme, Mergers and acquisitions, Online shopping, Reinsurance, Security (finance), Afterpay

SAN DIEGO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of the following companies.

Key Points: 
  • SAN DIEGO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of the following companies.
  • Investors are encouraged to submit their information to Johnson Fistel if they are interested in being appointed as Lead Plaintiff.
  • To join this action, you can click or copy and paste the link below into a browser:
    There is no cost or obligation to you.
  • An investor's ability to share any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff.

Castle Biosciences to Present Data Supporting the Clinical Value of Its Suite of Skin Cancer Tests through Multiple Oral Presentations at the 2022 American Society for Dermatologic Surgery (ASDS) Annual Meeting

Retrieved on: 
Monday, October 10, 2022
Research, Surgery, Genetics, Biotechnology, Other Health, Health, Other Science, Science, Oncology, Aurora, LinkedIn, SLN, Uncertainty, Internal Security Act (Singapore), Dermatology, Risk, SEC, National Comprehensive Cancer Network, ACMS, Society, American College of Mohs Surgery, Patient, NCCN, SEER, Surveillance, Twitter, Publication, Instagram, List of life sciences, Annual general meeting, Securities Act of 1933, Metastasis, Nasdaq, Sentinel lymph node, Malignancy, Company, Health, Atopic dermatitis, Skin, SCC, Castle, Recurrence, Survival, Melanoma, GEP, CSCC, P.C, Disease management, ASDS, American College, Uveal melanoma, Skin cancer, Securities Exchange Act of 1934, Pharmaceutical industry, Medical imaging, Medical device, Medicine, Silviculture, Facebook, Epidemiology

97% of respondents were at least somewhat familiar with or had used the DecisionDx-SCC test.

Key Points: 
  • 97% of respondents were at least somewhat familiar with or had used the DecisionDx-SCC test.
  • DecisionDx-Melanomas clinical value is supported by more than 35 peer-reviewed and published studies, providing confidence in disease management plans that incorporate the tests results.
  • Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care.
  • Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make.

LifeStance Health Class Action Complaint Filed: Johnson Fistel, Globally-Recognized Law Firm Encourages Shareholders to Submit Their LifeStance Health Losses

Retrieved on: 
Thursday, August 11, 2022
Internal Security Act (Singapore), GLOBE, Learning, Lists of action films, LLP, Health, Court, COVID-19, SAN, NASDAQ, Life, Securities Act of 1933, Physician, Tobacco

The class action is on behalf of shareholders who purchased or otherwise acquired LifeStance Health in or traceable to LifeStance Health June 2021 initial public offering (the IPO).

Key Points: 
  • The class action is on behalf of shareholders who purchased or otherwise acquired LifeStance Health in or traceable to LifeStance Health June 2021 initial public offering (the IPO).
  • A lead plaintiff will act on behalf of all other class members in directing the LifeStance Health class-action lawsuit.
  • An investor's ability to share any potential future recovery of the LifeStance Health class action lawsuit is not dependent upon serving as lead plaintiff.
  • Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia.

Investigation Alert HMBL, OKTA, CDNA: Johnson Fistel, LLP Encourages Long-Term Investors to Contact the Firm; Should Management be Held Accountable for Investors’ Losses?

Retrieved on: 
Tuesday, July 26, 2022
LLP, Exchange, Physician, Securities Act of 1933, Risk, Marketing, ETX, OKTA, NASDAQ, CDNA, Company, Lists of schools in England, Class Action, Internal Security Act (Singapore), OTC, Security (finance), Online shopping, Pharmaceutical industry, Okta

The complaint also alleges that the defendants violated provisions of the Securities Act by selling its unregistered securities (BLOCK ETX digital assets) to investors.

Key Points: 
  • The complaint also alleges that the defendants violated provisions of the Securities Act by selling its unregistered securities (BLOCK ETX digital assets) to investors.
  • Johnson Fistel, LLP is investigating potential claims on behalf of Okta, Inc. ("Okta") (NASDAQ: OKTA) against certain of its officers and directors.
  • Johnson Fistel, LLP is investigating potential claims on behalf of CareDx, Inc (NASDAQ: CDNA) against certain of its officers and directors.
  • Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia.